KLF10, transforming growth factor-β-inducible early gene 1, acts as a tumor suppressor

Biochemical and Biophysical Research Communications

Volumn 419, Issue 2, 2012, Pages 388-394

  Song, Ki Duk ^a   Kim, Duk Jung ^b   Lee, Jong Eun ^c   Yun, Cheol Heui ^a   Lee, Woon Kyu ^d  

^a Seoul National University   (South Korea)

^b The Institute of Hankook Life Science   (South Korea)

^c Yonsei University   (South Korea)

^d Inha University School of Medicine   (South Korea)

Author keywords

DMBA TPA; Kr ppel like factor 10; P21WAF1 CIP1; Sp1 binding sites; Tumor suppressor

Indexed keywords

KRUPPEL LIKE FACTOR 10; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN P21; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PAPILLOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SKIN CARCINOGENESIS; TRANSCRIPTION INITIATION; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; PAPILLOMA; PROMOTER REGIONS, GENETIC; PYRIDINES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 84862804986     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.032     Document Type: Article

References (30)

1. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1-and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 2001, 188:143-160.
2. Bureau C., Hanoun N., Torrisani J., et al. Expression and function of Krüppel-like factors (KLF) in carcinogenesis. Curr. Genomics 2009, 10:353-360.
3. Chen X., Johns D.C., Geiman D.E., et al. Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 2001, 276:30423-30428.
4. Narla G., Heath K.E., Reeves H.L., et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001, 294:2563-2566.
5. Subramaniam M., Harris S.A., Oursler M.J., et al. Identification of a novel TGF-β-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 1995, 23:4907-4912.
6. Ellenrieder V., Fernandez Zapico M.E., Urrutia R. TGFβ-mediated signaling and transcriptional regulation in pancreatic development and cancer. Curr. Opin. Gastroenterol. 2001, 17:434-440.
7. Yajima S., Lammers C.H., Lee S.H., et al. Cloning and characterization of murine glial cell-derived neurotrophic factor inducible transcription factor (MGIF). J. Neurosci. 1997, 17:8657-8666.
8. Hefferan T.E., Reinholz G.G., Rickard D.J., et al. Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-β action in human osteoblast cells. J. Biol. Chem. 2000, 275:20255-20259.
9. Chalaux E., López-Rovira T., Rosa J.L., et al. A zinc-finger transcription factor induced by TGF-β promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett. 1999, 457:478-482.
10. Eid M.A., Kuma M.V., Iczkowski K.A., et al. Expression of early growth response genes in human prostate cancer. Cancer Res. 1998, 58:2461-2468.
11. Subramaniam M., Hefferan T.E., Tau K., et al. Tissue, cell type, and breast cancer stage-specific expression of a TGFβ-inducible early transcription factor gene. J. Cell. Biochem. 1998, 68:226-236.
12. Reinholz M.M., An M.W., Johnsen S.A., et al. Differential gene expression of TGF-β inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Res. Treat. 2004, 86:75-88.
13. Zohrabian V.M., Nandu H., Gulati N., et al. Gene expression profiling of metastatic brain cancer. Oncol. Rep. 2007, 18:321-328.
14. Arf predisposes mice to tumorigenesis. Nature 2001, 413:86-91.
15. Ellwanger K., Saito H., Clément-Lacroix P., et al. Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol. Cell. Biol. 2008, 28:4875-4882.
16. Subramaniam M., Gorny G., Johnsen S.A., et al. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol. Cell. Biol. 2005, 25:1191-1199.
17. Yuspa S.H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res. 1994, 54:1178-1189.
18. Brown K., Buchmann A., Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. USA 1990, 87:538-543.
19. Biggs J.R., Kudlow J.E., Kraft A.S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 1996, 271:901-906.
20. El-Deiry W.S., Tokino T., Velculescu V.E., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
21. Rajamannan N.M., Subramaniam M., Abraham T.P., et al. TGFβ inducible early gene-1 (TIEG1) and cardiac hypertrophy: discovery and characterization of a novel signaling pathway. J. Cell. Biochem. 2007, 100:315-325.
22. Venuprasad K., Huang H., Harada Y., et al. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 2008, 9:245-253.
23. Cao Z., Wara A.K., Icli B., et al. Krüppel-like factor KLF10 targets transforming growth factor-β1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J. Biol. Chem. 2009, 284:24914-24924.
24. Zhao Y., Oberley T.D., Chaiswing L., et al. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 2002, 21:3836-3846.
25. Bierie B., Moses H.L. TGF-β: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 2006, 6:506-520.
26. Yanagihara K., Tsumuraya M. Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res. 1992, 52:4042-4045.
27. Glick A.B., Kulkarni A.B., Tennenbaum T., et al. Loss of expression of transforming growth factor in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA 1993, 90:6076-6080.
28. Wu J., Lingrel J.B. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 2002, 23:8088-8096.
29. Zhang W., Geiman D.E., Shields J.M., et al. The gut-enriched Krüppel-like factor (Krüppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem. 2000, 275:13918-18391.
30. Chrisman H.R., Tindall D.J. Identification and characterization of a consensus DNA binding element for the zinc finger transcription factor TIEG/EGRalpha. DNA Cell Biol. 2003, 22:187-199.